Safety and Tolerability of Long-term Administration of OROS Hydromorphone HCI (Slow Release) in Cancer Pain
Clinical trial NCT00410787 · COMPLETED
Trial details
- NCT number
- NCT00410787
- Sponsor
- Alza Corporation, DE, USA
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.